The Closed-Loop Skincare System That's Leading the Industry
In an era where consumers demand efficacy, safety, and scientific validation in their skincare routines, Derminous has redefined at-home beauty with its GeneLift™ Micro-Infusion System—a fully integrated, closed-loop skincare protocol that bridges clinical dermatology and daily self-care. Unlike conventional serums or microneedling kits, this system combines a 24K gold-coated micro-infusion device, patent-backed active ingredients, and a four-phase ritual (Activate → Infuse → Repair → Seal) to deliver measurable anti-aging results without pain, downtime, or professional intervention[1] .

At the core of GeneLift™ lies a triad of clinically validated technologies: PDRN (Polydeoxyribonucleotide) for cellular regeneration[2] , acetyl hexapeptide-8 (a synthetic “snake venom” peptide) to relax dynamic wrinkles[3] , and a proprietary nicotinamide formulation engineered for enhanced stability and brightness without irritation[4] . These actives are delivered via medical-grade, single-use micro-channels created by the 24K gold-tipped applicator—leveraging gold’s natural anti-inflammatory and antimicrobial properties to minimize redness while boosting absorption by up to 300% compared to topical application alone[5] .

What truly sets Derminous apart is its closed-loop design: every component—from serum to post-treatment mask to recovery cream—is formulated to work synergistically. The post-infusion mask, enriched with recombinant fibronectin and mussel extract, immediately calms micro-injuries, while the final lifting cream locks in actives with squalane and soluble collagen. This end-to-end system ensures no active is wasted and no barrier is compromised—aligning perfectly with the brand’s ethos of “empowering home-based clinical care”[6] .
Backed by patents such as ZL202111504220.4 (synthesis of acetyl hexapeptide-8) and ZL2020116206743 (controlled nicotinamide purity), Derminous doesn’t just promise transformation—it delivers a replicable, science-led ritual. Users report visible firming and luminosity within 2–4 weeks, with optimal results achieved through biweekly use[7] . In a market saturated with “clean” claims and vague promises, Derminous stands out by offering transparency, traceable innovation, and real epidermal change.
As the line between medical aesthetics and consumer skincare continues to blur, Derminous’ GeneLift™ represents not just a product—but a paradigm shift: beauty that begins in the lab, lives on your shelf, and reveals itself in your reflection.





Footnotes
Footnotes
-
Derminous Official Brand Philosophy. Derminous: Science-Backed Skincare for Home Use. https://www.derminous.com/pages/our-science↩
-
PDRN in Dermatology. Journal of Cosmetic Dermatology, 2021. https://doi.org/10.1111/jocd.14023↩
-
Acetyl Hexapeptide-8 Mechanism. International Journal of Molecular Sciences, 2020. https://www.mdpi.com/1422-0067/21/12/4355↩
-
Nicotinamide Stability & Efficacy. Dermatologic Therapy, 2022. https://doi.org/10.1002/dth.15432↩
-
Transdermal Enhancement via Microneedling. Advanced Drug Delivery Reviews, 2019. https://doi.org/10.1016/j.addr.2019.07.002↩
-
“Empowering Home-Based Clinical Care” – Derminous Founder’s Vision Statement. https://www.derminous.com/pages/our-story↩
-
Clinical User Feedback & Usage Protocol. Derminous GeneLift™ User Manual, 2025 Edition. https://www.derminous.com/pages/gene-lift-guide↩





